3Dieterle F,Marrer E,Suzuki E,et al.Monitoring kidney safety in drug deve-lopment:emerging technologies and their implications[J].Curr Opin Drug Discov Devel,2008,11(1):60-71.
7Solomon R,Dumouchel W.Contrast media and nephropathy:findings from systematic analysis and Food and Drug Administration reports of adverse effects[J].Invest Radiol,2006,41(8):651-660.
